سعر كيميفيب 300 مجم 20 كبسولة 2022

Kemifib fenofibrate 300 mg oral capsules, pack of 20, by Chemipharm (Egypt).

• Severe hypertriglyceridaemia with or without low HDL cholesterol, in adults, alongside diet.Population: AdultsANSM - Base de données publique des médicaments (France)
• Mixed hyperlipidaemia when a statin is contraindicated or not tolerated.Population: AdultsANSM - Base de données publique des médicaments (France)
• Mixed hyperlipidaemia in patients at high cardiovascular risk, in addition to a statin, when triglycerides and HDL are not adequately controlled.Population: AdultsANSM - Base de données publique des médicaments (France)

• Digestive disorders (dyspepsia), raised transaminases, muscle effects, skin reactions including photosensitivity, gallstones; rarely interstitial pneumopathy.International label, equivalent formulation · ANSM - Base de données publique des médicaments (France)

• Hepatic insufficiency; renal insufficiency; children; hypersensitivity to fenofibrate or excipients; known photoallergy or phototoxicity with fibrates or ketoprofen.International label, equivalent formulation · ANSM - Base de données publique des médicaments (France)

• Muscle toxicity including rare rhabdomyolysis; risk higher with renal impairment, hypothyroidism, alcohol abuse, age over 70 and with statins or other fibrates; check CK if myalgia or weakness occurs.International label, equivalent formulation · ANSM - Base de données publique des médicaments (France)
• Monitor transaminases every 3 months during the first 12 months; stop if levels exceed 3 times the upper limit of normal. Pancreatitis has been reported. Capsules contain lactose.International label, equivalent formulation · ANSM - Base de données publique des médicaments (France)

• Statins (HMG-CoA reductase inhibitors) and other fibratesIncreased risk of serious muscle toxicity; use the combination with caution and monitor.ANSM - Base de données publique des médicaments (France)
• Oral anticoagulants (vitamin K antagonists)Enhanced anticoagulant effect and bleeding risk; reduce anticoagulant dose by about one third at the start and monitor INR.ANSM - Base de données publique des médicaments (France)
• CiclosporinReversible decline in renal function reported; monitor renal function.ANSM - Base de données publique des médicaments (France)

• No adequate human data; use in pregnancy only for major hypertriglyceridaemia after careful benefit-risk assessment.International label, equivalent formulation · ANSM - Base de données publique des médicaments (France)
• Breastfeeding is not advised (déconseillé) during treatment.International label, equivalent formulation · ANSM - Base de données publique des médicaments (France)

English text not available for this section.